Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016 (2016), Article ID 5807346, 9 pages
http://dx.doi.org/10.1155/2016/5807346
Review Article

Combining Whole-Brain Radiotherapy with Gefitinib/Erlotinib for Brain Metastases from Non-Small-Cell Lung Cancer: A Meta-Analysis

1Department of Neurosurgery, First Clinical Medical College of Lanzhou University, Lanzhou 730000, China
2Evidence-Based Medicine Center of Lanzhou University, Lanzhou 730000, China
3Key Laboratory of Evidence-Based Medicine and Knowledge Translation of Gansu Province, Lanzhou 730000, China
4Department of Neurosurgery, Affiliated Hospital, Medical College of Chinese People’s Armed Police, Tianjin 300162, China

Received 3 July 2015; Accepted 2 December 2015

Academic Editor: Jun Deng

Copyright © 2016 Mao-hua Zheng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Mao-hua Zheng, Hong-tao Sun, Ji-guang Xu, et al., “Combining Whole-Brain Radiotherapy with Gefitinib/Erlotinib for Brain Metastases from Non-Small-Cell Lung Cancer: A Meta-Analysis,” BioMed Research International, vol. 2016, Article ID 5807346, 9 pages, 2016. doi:10.1155/2016/5807346